Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01145690
Other study ID # SOFIE-5YFU
Secondary ID
Status Completed
Phase N/A
First received June 15, 2010
Last updated October 25, 2010
Start date June 2010
Est. completion date September 2010

Study information

Verified date June 2010
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Observational

Clinical Trial Summary

Social anxiety disorder (SAD) is one of the most prevalent anxiety disorders in the western world. Cognitive behavioural therapy (CBT) is the psychological treatment that has the largest empirical support. However, the availability to CBT is very limited in Sweden due to lack of therapists with proper training. Therefore it is important to evaluate alternative forms of treatment that are more time efficient. One of these methods is Internet based self-help therapy, which has proven to be an effective treatment for social anxiety disorder.

In this study, the investigators aim to conduct a follow-up assessment five years after completed Internet-based CBT. Participants received treatment within the context of a randomised controlled trial conducted in 2005. Thus, in the present study there will be no treatment interventions, only assessment.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 2010
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Must have a primary diagnosis of social phobia

Exclusion Criteria:

- Substance abuse during the last 6 months

- Other dominating diagnosis (not phobic personality disorder)

- A history of bipolar disorder or psychosis

- Major depression according to DSM-IV and >20 on madrs-s

- Risk of suicide

- Start of medication or change of dosis during the last 2 months

- Other parallel psychological treatment

- Previous CBT (last 3 years) for social phobia

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Locations

Country Name City State
Sweden Psykiatri Sydväst, Stockholm County Council Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of social anxiety and avoidance - Liebowitz Social Anxiety Scale (LSAS) 5-year follow-up No
Secondary Measures of social anxiety in interaction and performance situations - SIAS & SPS 5-year follow-up No
Secondary Measure of depressive symptoms - MADRS-S 5-year follow-up No
Secondary Measure of general anxiety - BAI 5-year follow-up No
Secondary Measure of quality of life - QOLI 5-year follow-up No
Secondary Measure of social anxiety disorder diagnosis - SPSQ 5-year follow-up No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06274112 - Using TMS to Understand Neural Processes of Social Motivation N/A
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00684541 - Interpretation Modification Program for Social Phobia N/A
Completed NCT00684320 - Attention Disengagement Training for Social Phobia N/A
Completed NCT03247075 - Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Withdrawn NCT04622930 - Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD) N/A
Active, not recruiting NCT05018312 - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Completed NCT05858294 - The Safety, Acceptability and Efficacy of Alena N/A
Active, not recruiting NCT05600114 - Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Not yet recruiting NCT02924610 - Brief Intervention to Reduce Fear Phase 4
Active, not recruiting NCT02592564 - Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Unknown status NCT01712321 - Study of Vilazodone to Treat Social Anxiety Disorder N/A
Completed NCT01320800 - CBT for Social Anxiety Disorder Delivered by School Counselors Phase 2
Completed NCT00872820 - Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder N/A
Completed NCT00485888 - Flushing in Social Anxiety Disorder on Cipralex Phase 2